Alpha Tau Medical (DRTSW) Non Operating Income (2021 - 2025)
Alpha Tau Medical (DRTSW) posted Non Operating Income of -$867000.0 for Q4 2025, down 189.94% sequentially from $964000.0 in Q3 2025, and down 111.12% YoY from $7.8 million in Q4 2024.
Alpha Tau Medical (DRTSW) Non Operating Income (2021 - 2025) Analysis & Trends
Alpha Tau Medical has reported Non Operating Income for 5 years, with the latest figure at -$867000.0 in Q4 2025.
- Quarterly Non Operating Income fell 111.12% year-over-year to -$867000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$218000.0 (down 105.07% YoY) and the FY2025 annual result came in at -$218000.0, down 105.07% from the prior year.
- Non Operating Income retreated to -$867000.0 in Q4 2025 per DRTSW's latest filing, from $964000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $17.0 million in Q1 2022 and troughed at -$6.0 million in Q2 2022.
- A 5-year average of $1.2 million and a median of -$478000.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income jumped 328.48% in 2023, then tumbled 438.28% in 2024.
- Over 5 years, Non Operating Income stood at $9.0 million in 2021, then plunged by 151.22% to -$4.6 million in 2022, then surged by 328.48% to $10.5 million in 2023, then retreated by 25.7% to $7.8 million in 2024, then sank by 111.12% to -$867000.0 in 2025.
- According to Business Quant data, Non Operating Income over the past three periods registered -$867000.0, $964000.0, and $401000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Alpha Tau Medical | 383.00 Mn | 200.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -867,000.00 |
| Sep 30, 2025 | 964,000.00 |
| Jun 30, 2025 | 401,000.00 |
| Mar 31, 2025 | -716,000.00 |
| Dec 31, 2024 | 7.80 Mn |
| Sep 30, 2024 | -1.37 Mn |
| Jun 30, 2024 | -1.69 Mn |
| Mar 31, 2024 | -444,000.00 |
| Dec 31, 2023 | 10.49 Mn |
| Sep 30, 2023 | -3.97 Mn |
| Jun 30, 2023 | 499,000.00 |
| Mar 31, 2023 | -478,000.00 |
| Dec 31, 2022 | -4.59 Mn |
| Sep 30, 2022 | -4.74 Mn |
| Jun 30, 2022 | -6.02 Mn |
| Mar 31, 2022 | 16.96 Mn |
| Mar 31, 2021 | 8.97 Mn |